QIAGEN powered by

LabCorp uses QCI

and HGMD to improve identification and interpretation of genetic variants within inherited diseases.

Press Releases

QIAGEN launches QIAGEN Biomedical Knowledge Base

QIAGEN gives drug research direct access to world-leading data with launch of QIAGEN Biomedical Knowledge Base, supporting data science applications in pharmaceuticals and biotechnology that are becoming ever more important for drug discovery.

QIAGEN partners with ATCC

ATCC’s collection of high-fidelity authenticated DNA-seq and RNA-seq datasets to be included in QIAGEN’s databases for biotechnology and pharmaceutical companies for research purposes.

Qiagen Launches 'Digital Partner' Program

QIAGEN has launched a "Digital Insights Partnership" program designed to expand the market for its bioinformatics products through various third-party collaborations and deals

QIAGEN and Illumina Partner

The agreement grants QIAGEN non-exclusive rights to develop and globally commercialize IVD kits to be used together with Illumina’s MiSeq™ Dx and NextSeq™ 550Dx Systems

1 million patients analyzed

QCI, a clinical decision support platform for interpretation and reporting of variants derived from analysis of next-generation sequencing (NGS) data, has achieved a milestone of more than 1 million patient test cases analyzed and interpreted

Global Initiative to combat antimicrobial resistance

A new initiative to help address the global crisis of antibiotic-resistant pathogens. ...